New hope for advanced breast cancer: experimental drug cocktails enter human testing
NCT ID NCT07389733
Summary
This early-stage clinical trial is testing several combinations of experimental drugs (HRS-6208, HRS-8080, HRS-6209) with existing breast cancer medications (fulvestrant, letrozole) for people with advanced, spreading breast cancer that cannot be surgically removed. The main goals are to find safe doses and see if these combinations show early signs of helping control the cancer. The study will enroll about 180 adult women to monitor side effects and see how the drugs affect tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED UNRESECTABLE OR METASTATIC BREAST CANCER OF ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610044, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.